Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Feasibility of Circulating Tumor DNA Analysis in Patients with Follicular Lymphoma.

Cancer research and treatment - 1 Jul 2024

Yoon Sang Eun, Shin Seung-Ho, Nam Dae Keun, Cho Junhun, Kim Won Seog, Kim Seok Jin

Abstract excerpt

PURPOSE: The feasibility of sequencing circulating tumor DNA (ctDNA) in plasma as a biomarker to predict early relapse or poor prognosis in patients with follicular lymphoma (FL) receiving systemic immunochemotherapy is not clear. MATERIALS AND METHODS: We sequenced DNA from cell-free plasma that was serially obtained from newly diagnosed FL patients undergoing systemic immunochemotherapy. The mutation profiles...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Biomarkers, Tumor
Share to Circulating Tumor DNA

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Feasibility Studies

Share to Lymphoma, Follicular

Share to Prognosis

Share to Rituximab

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 38228081
DOI: 10.4143/crt.2023.869
PMCID: PMC11261198

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Feasibility of Circulating Tumor DNA Analysis in Patients with Follicular Lymphoma.PMID 38228081Read ↗

Circulating tumor DNA as a powerful tool in diagnostics and treatment outcome prediction - focus on large B-cell lymphomas and follicular lymphomas.Semantic proximity Read ↗

Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors.Semantic proximity Read ↗

Real-Life Disease Monitoring in Follicular Lymphoma Patients Using Liquid Biopsy Ultra-Deep Sequencing and PET/CTSemantic proximity Read ↗

Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma.Semantic proximity Read ↗

The prognostic value of clonal heterogeneity and quantitative assessment of plasma circulating clonal IG-VDJ sequences at diagnosis in patients with follicular lymphoma.Semantic proximity Read ↗

Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma Precursors.Semantic proximity Read ↗

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.Semantic proximity Read ↗

Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation.Semantic proximity Read ↗

The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival.Semantic proximity Read ↗

EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment.Semantic proximity Read ↗

Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma.Semantic proximity Read ↗

Single gene mutations and prognosis in limited-stage follicular lymphoma treated with radiation therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.